Stephens P - Search Results

1

Mechanism of action of certolizumab pegol (CDP870): in vitro comparison with other anti-tumor necrosis factor alpha agents.

Nesbitt A, Fossati G, Bergin M, Stephens P, Stephens S, Foulkes R, Brown D, Robinson M, Bourne T. Nesbitt A, et al. Among authors: stephens p, stephens s. Inflamm Bowel Dis. 2007 Nov;13(11):1323-32. doi: 10.1002/ibd.20225. Inflamm Bowel Dis. 2007. PMID: 17636564

2

Neutrophil adhesion: a point for therapeutic intervention?

Robinson MK, Stephens PE. Robinson MK, et al. Among authors: stephens pe. Curr Opin Biotechnol. 1992 Dec;3(6):662-7. doi: 10.1016/0958-1669(92)90013-9. Curr Opin Biotechnol. 1992. PMID: 1369417 Review.

3

In vitro and in vivo characterisation of anti-murine IL-13 antibodies recognising distinct functional epitopes.

Berry LM, Adams R, Airey M, Bracher MG, Bourne T, Carrington B, Cross AS, Davies GC, Finney HM, Foulkes R, Gozzard N, Griffin RA, Hailu H, Lamour SD, Lawson AD, Lightwood DJ, McKnight AJ, O'Dowd VL, Oxbrow AK, Popplewell AG, Shaw S, Stephens PE, Sweeney B, Tomlinson KL, Uhe C, Palframan RT. Berry LM, et al. Among authors: stephens pe. Int Immunopharmacol. 2009 Feb;9(2):201-6. doi: 10.1016/j.intimp.2008.11.001. Epub 2008 Nov 27. Int Immunopharmacol. 2009. PMID: 19041426

4

Porcine E-selectin: cloning and functional characterization.

Tsang YT, Stephens PE, Licence ST, Haskard DO, Binns RM, Robinson MK. Tsang YT, et al. Among authors: stephens pe. Immunology. 1995 May;85(1):140-5. Immunology. 1995. PMID: 7543446 Free PMC article.

5

A short treatment with an antibody to sclerostin can inhibit bone loss in an ongoing model of colitis.

Eddleston A, Marenzana M, Moore AR, Stephens P, Muzylak M, Marshall D, Robinson MK. Eddleston A, et al. Among authors: stephens p. J Bone Miner Res. 2009 Oct;24(10):1662-71. doi: 10.1359/jbmr.090403. J Bone Miner Res. 2009. PMID: 19419292 Free article.

6

Antibody against the Leu-CAM beta-chain (CD18) promotes both LFA-1- and CR3-dependent adhesion events.

Robinson MK, Andrew D, Rosen H, Brown D, Ortlepp S, Stephens P, Butcher EC. Robinson MK, et al. Among authors: stephens p. J Immunol. 1992 Feb 15;148(4):1080-5. J Immunol. 1992. PMID: 1371129

7

Antibodies that activate beta 2 integrins can generate different ligand binding states.

Ortlepp S, Stephens PE, Hogg N, Figdor CG, Robinson MK. Ortlepp S, et al. Among authors: stephens pe. Eur J Immunol. 1995 Mar;25(3):637-43. doi: 10.1002/eji.1830250302. Eur J Immunol. 1995. PMID: 7535698

8

KIM127, an antibody that promotes adhesion, maps to a region of CD18 that includes cysteine-rich repeats.

Stephens P, Romer JT, Spitali M, Shock A, Ortlepp S, Figdor CG, Robinson MK. Stephens P, et al. Cell Adhes Commun. 1995 Dec;3(5):375-84. doi: 10.3109/15419069509081292. Cell Adhes Commun. 1995. PMID: 8640375

9

A tumor-associated beta 1 integrin mutation that abrogates epithelial differentiation control.

Evans RD, Perkins VC, Henry A, Stephens PE, Robinson MK, Watt FM. Evans RD, et al. J Cell Biol. 2003 Feb 17;160(4):589-96. doi: 10.1083/jcb.200209016. Epub 2003 Feb 10. J Cell Biol. 2003. PMID: 12578911 Free PMC article.

10

E-selectin binds to squamous cell carcinoma and keratinocyte cell lines.

Allen MH, Robinson MK, Stephens PE, MacDonald DM, Barker JN. Allen MH, et al. Among authors: stephens pe. J Invest Dermatol. 1996 Apr;106(4):611-5. doi: 10.1111/1523-1747.ep12345385. J Invest Dermatol. 1996. PMID: 8617993 Free article.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

864 results

Search Page